Advertisement
February 1, 20264 min readMedicines & Drugs

Allopurinol API: Gout Management, Mechanism, and Quality

Allopurinol is a xanthine oxidase inhibitor widely used to control uric acid levels. This article focuses on the API characteristics relevant for formulation development.

Allopurinol API: Gout Management, Mechanism, and Quality

Introduction to Allopurinol API

Allopurinol is a xanthine oxidase inhibitor used primarily for long‑term management of chronic gout and conditions associated with hyperuricemia, such as chemotherapy‑induced tumor lysis syndrome. As an API, it is widely used in oral tablet formulations.

Key Indications

  • Chronic gout with recurrent attacks or tophi
  • Hyperuricemia secondary to malignancy or chemotherapy
  • Recurrent uric acid kidney stones

Mechanism of Action

Allopurinol and its active metabolite oxypurinol inhibit xanthine oxidase, the enzyme responsible for converting hypoxanthine and xanthine into uric acid. This leads to reduced serum and urinary uric acid levels and helps prevent crystal deposition in joints and kidneys.

API Quality Considerations

Important quality aspects for Allopurinol API include control of polymorphic form, residual solvents, heavy metals, and related impurities. Stability data under ICH conditions should be available, and material is typically stored in well‑closed containers away from excessive moisture and light.

Advertisement

Share this article:

V

About Vubrix Pharma Team

Our team of pharmacists and medical writers share accurate, easy-to-understand medicine information for healthcare professionals and patients.

Advertisement